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Imaging of patients with acute ischemic stroke is fascinating,
because is offers the opportunity to better understand and treat a
disabling disease with variable causes and pathophysiology. We
appreciated computed tomography (CT) in the early 1970s as the
first method demonstrating the diseased brain in vivo. In stroke
patients, CT detects hyperattenuating masses and arteries, hypoatte-
nuating brain tissue, and swelling of brain tissue without a change in
x-ray attenuation, and we diagnose hemorrhage, intra-arterial throm-
bus, ischemic brain edema, and tissue swelling due to vasodilatation
[1]. Because stroke is fortunately often not a fatal disease, autopsies
are rarely done and direct comparison between the image and the
stroke pathology is seldom possible. Therefore, we cannot be quite
sure that stroke patients without hyperattenuating substrates have
really no intracranial hemorrhage. Subtle hemorrhagic tissue trans-
formation of tiny amounts of blood in the cerebrospinal fluid may
remain undetected by CT. Stroke patients without hypoattenuating
tissue on CT may have no ischemic edema and no irreversible tissue
damage, but it is hard to prove. We are missing a gold standard to
determine the sensitivity and specificity of brain tissue imaging for
certain pathologies. The use of imaging modalities, e.g. the compari-
son between CT and magnetic resonance imaging (MRI), is of lim-
ited value as long as the specificity of findings is undetermined. The
recent paper of Jaillard et al. [2] is an example.
Jaillard et al. intended ‘to study the pathophysiology of early CT
signs’. They compared CT and MRI findings in 16 patients within
29 h of stroke onset. The CT was obtained 30 min to 24 h earlier than
MRI (mean 4:48 h) – interestingly, a common finding in papers com-
paring both modalities [3]. Why is MRI delayed in most studies com-
pared to CT? Based on this comparison with different intervals
between both assessments and at different timepoints of the evolving
ischemic tissue changes, the authors conclude that early CT signs
may show either preinfarction or ischemic penumbra. In particular,
they base this conclusion on the observation of patients who had a
follow-up T2-weighted MRI (T2WI) that matched the diffusion-
weighted image (DWI), but was smaller than the early CT findings.
The authors do not discuss whether T2WI is really the gold standard
for irreversible tissue damage and they do not describe the methods
of their follow-up imaging. Moreover, they do not describe which
‘CT sign’ appeared reversible. It would make sense to find that brain
tissue swelling due to compensatory arterial dilatation is reversible if
perfusion pressure increases, whereas hypoattenuating tissue repre-
sents ischemic edema and irreversible injury [4]. Unfortunately, the
images in this paper do not support the authors’ conclusions and may
even confuse the reader. The legends of figures 2 and 3 are apparently
interchanged. The CT scan in figure 2 of patient 2 has a very low
window level so that gray and white matter can hardly be distin-
guished. According to the legend, this CT was obtained at 3:20 h ‘af-
ter the patient’s worsening’, according to the figure at 11:20 h, and
according to the table at 6:20 h. Despite the low image quality, the
hypoattenuating upper lentiform nucleus and central white matter is
easily recognized and matches the DWI, rCBF and rCBV image at
26 h, and the T2WI at day 5. I wonder why this finding does not
appear in figure 1 in the template of patient 2.
The authors still emphasize that the reduction of diffusion is an
indicator for irreversible tissue damage. They did not report, how-
ever, whether the DWI lesions found in this series of patients
matched the lesions on follow-up imaging, e.g. with CT or MRI. They
do not discuss why a decrease in ADC triggered by a CBF of 40 ml/
100 g ! min [5] – far above the penumbra threshold – should mean
irreversible injury. Is decreased proton diffusion that can disappear
and reapper under experimental conditions [6] really fully explained
by ‘cytotoxic edema’ and does such cytotoxic edema eo ipso mean
irreversible damage? Do the authors think that disturbed proton dif-
fusion and hypoattenuating brain tissue represent the same patholo-
gy? In my view, it is premature to accept DWI as gold standard for
the pathophysiology of ischemic brain tissue. I see ample evidence,
however, that hypoattenuating brain tissue after arterial occlusion on
CT is a highly specific finding that represents net uptake of water and
irreversible injury.
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